Nakagawa Tomoo, Hocart Simon J, Schumann Michael, Tapia Jose A, Mantey Samuel A, Coy David H, Tokita Kenji, Katsuno Tatsuro, Jensen Robert T
Digestive Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health, Bethesda, MD 20892-1804, USA.
Biochem Pharmacol. 2005 Feb 15;69(4):579-93. doi: 10.1016/j.bcp.2004.11.003. Epub 2004 Dec 23.
The bombesin (Bn) receptor family includes the gastrin-releasing peptide (GRPR) and neuromedin B (NMBR) receptors, Bn receptor subtype 3 (BRS-3) and Bn receptor subtype 4 (BB(4)). They share 50% homology, yet their affinities for gastrin-releasing peptide (GRP) differ. The determinants of GRP high affinity for GRPR and BB(4), and low affinity for BRS-3 are largely unknown. To address this question we made an analysis of structural homologies in Bn receptor members correlated with their affinities for GRP to develop criteria to identify amino acids important for GRP selectivity. Fourteen differences were identified and each was mutated singly in GRPR to that found in hBRS-3. Eleven mutants had a loss of GRP affinity. Furthermore, three of four amino acids in the GRPR selected used a similar approach and previously reported to be important for high affinity Bn binding, were important for GRP affinity. Some GRPR mutants containing combinations of these mutations had greater decreases in GRP affinity than any single mutation. Particularly important for GRP selectivity were K101, Q121, A198, P199, S293, R288, T297 in GRPR. These results were confirmed by making the reverse mutations in BRS-3 to make GRP gain of affinity mutants. Modeling studies demonstrated a number of the important amino acids had side-chains oriented inward and within 6A of the binding pocket. These results demonstrated this approach could identify amino acids needed for GRP affinity and complemented results from chimera/mutagenesis studies by identifying which differences in the extracellular domains of Bn receptors were important for GRP affinity.
蛙皮素(Bn)受体家族包括胃泌素释放肽(GRPR)和神经介素B(NMBR)受体、Bn受体亚型3(BRS-3)和Bn受体亚型4(BB(4))。它们有50%的同源性,但它们对胃泌素释放肽(GRP)的亲和力不同。GRP对GRPR和BB(4)具有高亲和力而对BRS-3具有低亲和力的决定因素在很大程度上尚不清楚。为了解决这个问题,我们分析了Bn受体成员的结构同源性及其与GRP的亲和力,以制定识别对GRP选择性重要的氨基酸的标准。鉴定出14个差异,并且在GRPR中逐一将每个差异突变为在hBRS-3中发现的氨基酸。11个突变体丧失了GRP亲和力。此外,采用类似方法并先前报道对高亲和力Bn结合很重要的GRPR中四个氨基酸中的三个,对GRP亲和力也很重要。一些含有这些突变组合的GRPR突变体的GRP亲和力下降幅度比任何单个突变都更大。对GRP选择性特别重要的是GRPR中的K101、Q121、A198、P199、S293、R288、T297。通过在BRS-3中进行反向突变以产生GRP亲和力增加的突变体,证实了这些结果。建模研究表明,许多重要氨基酸的侧链向内定向且在结合口袋的6埃范围内。这些结果表明,这种方法可以识别GRP亲和力所需的氨基酸,并通过确定Bn受体细胞外结构域中的哪些差异对GRP亲和力很重要,补充了嵌合体/诱变研究的结果。